β-干扰素在多发性硬化症中的作用机制。 - Suppr

Suppr

超能文献

Mechanisms of action of interferon-beta in multiple sclerosis.

作者信息

Arnason B G, Dayal A, Qu Z X, Jensen M A, Genç K, Reder A T

机构信息

Department of Neurology and the Brain Research Institute, University of Chicago, IL 60637, USA.

出版信息

Springer Semin Immunopathol. 1996;18(1):125-48. doi: 10.1007/BF00792613.

DOI:10.1007/BF00792613

PMID:8984676

Abstract

摘要

相似文献

Mechanisms of action of interferon-beta in multiple sclerosis.β-干扰素在多发性硬化症中的作用机制。

Springer Semin Immunopathol. 1996;18(1):125-48. doi: 10.1007/BF00792613.

Targets for the therapeutic action of interferon-beta in multiple sclerosis.

Ann Neurol. 1996 Dec;40(6):825-6. doi: 10.1002/ana.410400602.

[Interferon-1 beta in the treatment of multiple sclerosis].

Nervenarzt. 1995 Sep;66(9 Suppl Interferon):1-16.

Interferon beta treatment of multiple sclerosis.

Neurology. 1994 Jan;44(1):186; author reply 188-90. doi: 10.1212/wnl.44.1.186-a.

Interferon beta treatment of multiple sclerosis.

Neurology. 1994 Jan;44(1):186; author reply 188-90. doi: 10.1212/wnl.44.1.186-b.

Interferon beta treatment of multiple sclerosis.

Neurology. 1994 Jan;44(1):186; author reply 188-90. doi: 10.1212/wnl.44.1.186.

[Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis].

Neurol Neurochir Pol. 2000;34(3 Suppl):63-9.

[Advances in the therapy of multiple sclerosis with interferon beta-1a].

Nervenarzt. 1997 Oct;68(10 Suppl):1-8.

Interferon beta treatment of multiple sclerosis.

Neurology. 1994 Jan;44(1):188; author reply 188-90. doi: 10.1212/wnl.44.1.188.

Interferon beta-1a and beta-1b for treatment of multiple sclerosis.

Lancet. 2002 Nov 2;360(9343):1428; author reply 1428-9. doi: 10.1016/S0140-6736(02)11384-5.

引用本文的文献

Relationship between Neutrophil-to-Lymphocyte Ratio and Stress in Multiple Sclerosis Patients.多发性硬化症患者中性粒细胞与淋巴细胞比值与应激的关系

J Clin Diagn Res. 2017 May;11(5):CC01-CC04. doi: 10.7860/JCDR/2017/24388.9764. Epub 2017 May 1.

Disease-modifying therapies and infectious risks in multiple sclerosis.多发性硬化症的疾病修正治疗和感染风险。

Nat Rev Neurol. 2016 Apr;12(4):217-33. doi: 10.1038/nrneurol.2016.21. Epub 2016 Mar 4.

Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon β-1b.干扰素β-1b诱导NCOA7抗氧化基因的一种独特亚型。

J Interferon Cytokine Res. 2015 Mar;35(3):186-99. doi: 10.1089/jir.2014.0115. Epub 2014 Oct 20.

Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis.干扰素-β-1b 诱导多发性硬化症短期和长期的治疗活性特征。

Pharmacogenomics J. 2013 Oct;13(5):443-51. doi: 10.1038/tpj.2012.27. Epub 2012 Jun 19.

Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.浆细胞样树突状细胞中与多发性硬化症相关和干扰素-β调节的基因表达。

J Neuroimmunol. 2012 Sep 15;250(1-2):99-105. doi: 10.1016/j.jneuroim.2012.05.013. Epub 2012 Jun 9.

The mechanism of action of interferon-β in relapsing multiple sclerosis.干扰素-β在复发型多发性硬化症中的作用机制。

CNS Drugs. 2011 Jun 1;25(6):491-502. doi: 10.2165/11591110-000000000-00000.

Chemotherapeutics in the treatment of multiple sclerosis.化疗在多发性硬化症治疗中的应用。

Ther Adv Neurol Disord. 2010 Sep;3(5):277-91. doi: 10.1177/1756285610379885.

The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.细胞因子作为免疫调节疗法对多发性硬化症心理影响的一种可能底物的作用。

Neurosci Behav Physiol. 2009 Jan;39(1):25-30. doi: 10.1007/s11055-008-9087-1.

N-acetyl-L-cysteine ameliorates the inflammatory disease process in experimental autoimmune encephalomyelitis in Lewis rats.N-乙酰-L-半胱氨酸可改善Lewis大鼠实验性自身免疫性脑脊髓炎的炎症疾病进程。

J Autoimmune Dis. 2005 May 3;2(1):4. doi: 10.1186/1740-2557-2-4.

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies.多发性硬化症患者中β干扰素的生物活性受治疗方案和中和抗体的影响。

J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259.

本文引用的文献

Eicosenoids Modify Experimental Allergic Encephalomyelitis.

Am J Ther. 1995 Sep;2(9):711-720. doi: 10.1097/00045391-199509000-00020.

All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis.

Arch Neurol. 1998 Mar;55(3):315-21. doi: 10.1001/archneur.55.3.315.

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b.接受β-1b干扰素治疗的多发性硬化症患者中分泌γ干扰素的细胞

Neurology. 1995 Dec;45(12):2173-7. doi: 10.1212/wnl.45.12.2173.

Validation of the functional assessment of multiple sclerosis quality of life instrument.多发性硬化症生活质量量表功能评估的验证

Neurology. 1996 Jul;47(1):129-39. doi: 10.1212/wnl.47.1.129.

Involvement of cytokines in acute neurodegeneration in the CNS.

Neurosci Biobehav Rev. 1993 Summer;17(2):217-27. doi: 10.1016/s0149-7634(05)80152-6.

Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin.重组人β-干扰素血清在健康志愿者体内的药代动力学及其对血清新蝶呤的影响。

Pharm Res. 1993 Apr;10(4):567-72. doi: 10.1023/a:1018902120023.

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.干扰素β-1b对复发缓解型多发性硬化有效。II. 一项多中心、随机、双盲、安慰剂对照试验的MRI分析结果。英属哥伦比亚大学多发性硬化/MRI研究组和干扰素β多发性硬化研究组。

Neurology. 1993 Apr;43(4):662-7. doi: 10.1212/wnl.43.4.662.

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.干扰素β-1b对复发缓解型多发性硬化症有效。I. 一项多中心、随机、双盲、安慰剂对照试验的临床结果。IFNB多发性硬化症研究组。

Neurology. 1993 Apr;43(4):655-61. doi: 10.1212/wnl.43.4.655.

Interferon beta in multiple sclerosis.多发性硬化症中的β干扰素

Neurology. 1993 Apr;43(4):641-3. doi: 10.1212/wnl.43.4.641.

Multiple sclerosis: remyelination of nascent lesions.多发性硬化症：新生病灶的髓鞘再生

Ann Neurol. 1993 Feb;33(2):137-51. doi: 10.1002/ana.410330203.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验